These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9724481)

  • 21. Prostaglandin E1 improves survival rate after 95% hepatectomy in rats.
    Togo S; Chen H; Takahashi T; Kubota T; Matsuo K; Morioka D; Watanabe K; Yamamoto H; Nagashima Y; Shimada H
    J Surg Res; 2008 May; 146(1):66-72. PubMed ID: 17599359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.
    Feld S; Li G; Wu A; Felli P; Amirian J; Vaughn WK; Gornet T; Swenson C; Smalling RW
    Am Heart J; 1996 Oct; 132(4):747-57. PubMed ID: 8831361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group.
    Silverman HJ; Slotman G; Bone RC; Maunder R; Hyers TM; Kerstein MD; Ursprung JJ
    Chest; 1990 Aug; 98(2):405-10. PubMed ID: 2198140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study.
    Ogawa K; Takei S; Inoue Y; Kanzaki J
    Otol Neurotol; 2002 Sep; 23(5):665-8. PubMed ID: 12218617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of primary liver graft nonfunction with prostaglandin E1.
    Greig PD; Woolf GM; Sinclair SB; Abecassis M; Strasberg SM; Taylor BR; Blendis LM; Superina RA; Glynn MF; Langer B
    Transplantation; 1989 Sep; 48(3):447-53. PubMed ID: 2675405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.
    Sinclair SB; Greig PD; Blendis LM; Abecassis M; Roberts EA; Phillips MJ; Cameron R; Levy GA
    J Clin Invest; 1989 Oct; 84(4):1063-9. PubMed ID: 2794044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.
    Cawello W; Schweer H; Müller R; Bonn R; Seyberth HW
    Eur J Clin Pharmacol; 1994; 46(3):275-7. PubMed ID: 8070511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous prostaglandin E1 in the treatment of venous ulcers--a double-blind, placebo-controlled trial.
    Rudofsky G
    Vasa Suppl; 1989; 28():39-43. PubMed ID: 2692199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
    Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
    Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of intraportal prostaglandin E1 administration after liver transplantation.
    Shin M; Song SH; Kim JM; Kim SJ; Joh JW; Lee SK; Kwon CH
    Transplant Proc; 2012 Mar; 44(2):500-4. PubMed ID: 22410055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
    Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
    Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of severe intermittent claudication with PGE1--a short-term vs a long-term infusion plan--a 20 week, European randomized trial--analysis of efficacy and costs.
    Belcaro G; Laurora G; Nicolaides AN; Agus G; Cesarone MR; DeSanctis MT; Incandela L; Ricci A; Cazaubon M; Ippolito E; Barsotti A; Vasdekis S; Ledda A; Iacobitti P; Christopoulos D; Errichi BM; Helmis H; Cornelli U; Ramaswami G; Bucci M; Ferrari PG; Corsi M; Pomante P; Mezzanotte L; Geroulakos G
    Angiology; 1998 Nov; 49(11):885-94; discussion 895. PubMed ID: 9822044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H
    Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
    Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
    Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of administering intraportal prostaglandin E1 postoperatively to hepatectomy patients with massive intraoperative blood loss.
    Katsuramaki T; Mukaiya M; Yamashiro K; Kimura H; Denno R; Hirata K
    Surg Today; 1996; 26(11):895-9. PubMed ID: 8931220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of intraportal administration of prostaglandin E1 on liver blood flow and liver function.
    Inagaki H; Kurokawa T; Nonami T; Miwa T; Nakao A; Takagi H
    Hepatogastroenterology; 1999; 46(29):2909-13. PubMed ID: 10576371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous infusion of prostagrandin E1 during and after gastrectomy on postoperative hepato-renal functions in senile patients].
    Murakawa T; Shimodate Y; Matsuki A; Tanaka T; Takeuchi M; Ino M; Tateoka H; Yokoyama M; Ohishi S
    Masui; 1996 Mar; 45(3):356-61. PubMed ID: 8721140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.